Fresenius Medical Care
(ETR) FME
Fresenius Medical Care Financials at a Glance
Market Cap
$10.72B
Revenue (TTM)
$19.63B
Net Income (TTM)
$978.29M
EPS (TTM)
$3.37
P/E Ratio
11.40
Dividend
$1.44
Beta (Volatility)
-0.02 (Low)
Dividend
$1.44
Beta (Volatility)
-0.02 (Low)
Price
$38.94
Volume
668,339
Open
$38.31
Price
$38.94
Volume
668,339
Open
$38.31
Previous Close
$38.94
Daily Range
$38.22 - $39.16
52-Week Range
$35.67 - $54.02
Dividend
$1.44
Beta (Volatility)
-0.02 (Low)
Price
$38.94
Volume
668,339
Open
$38.31
Previous Close
$38.94
Daily Range
$38.22 - $39.16
52-Week Range
$35.67 - $54.02
FME News
FME: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Fresenius Medical Care
Industry
Healthcare Providers and Services
Sector
Health CareEmployees
109,698
CEO
Helen Giza, MBA
Headquarters
Bad Homburg, 61352, DE
FME Financials
Key Financial Metrics (TTM)
Gross Margin
26%
Operating Margin
9%
Net Income Margin
5%
Return on Equity
7%
Return on Capital
7%
Return on Assets
3%
Earnings Yield
8.77%
Dividend Yield
0.04%
Payout Ratio
43.19%
Stock Overview
Market Cap
$10.72B
Shares Outstanding
279.29M
Volume
668.34K
Short Interest
0.00%
Avg. Volume
950.77K
Financials (TTM)
Gross Profit
$5.03B
Operating Income
$1.84B
EBITDA
$3.34B
Operating Cash Flow
$2.68B
Capital Expenditure
$915.37M
Free Cash Flow
$1.77B
Cash & ST Invst.
$1.73B
Total Debt
$13.70B
Fresenius Medical Care Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$5.07B
-0.3%
Gross Profit
$1.39B
+9.3%
Gross Margin
27.40%
N/A
Market Cap
$10.72B
N/A
Market Cap/Employee
$95.73K
N/A
Employees
112,035
N/A
Net Income
$327.00M
+388.7%
EBITDA
$938.00M
+29.4%
Quarterly Fundamentals
Net Cash
$11.98B
-25.6%
Accounts Receivable
$3.14B
-19.9%
Inventory
$2.14B
+3.5%
Long Term Debt
$11.50B
+17.9%
Short Term Debt
$2.20B
+80.4%
Return on Assets
3.16%
N/A
Return on Invested Capital
7.26%
N/A
Free Cash Flow
$578.67M
-2.1%
Operating Cash Flow
$1.00B
+20.4%